✦ LIBER ✦

Interim Analysis of a Phase II Trial to Examine Use of Postchemotherapy Volumes After Neo-adjuvant Treatment of Squamous Cell Carcinomas of the Head and Neck

✍ Scribed by Caudell, J.J.; Ma, J.; Jennelle, R.; Hamilton, R.D.; Pitman, K.; Otto, K.; Jefferson, G.; Vijayakumar, S.

Book ID: 123004590
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 87 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.1266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-Year Clinical Outcome and Quality

Three-Year Clinical Outcome and Quality of Life Interim Analysis of a Phase 2 Trial to Examine Use of Postchemotherapy Volumes After Neoadjuvant Treatment of Squamous Cell Carcinomas of the Head and Neck

✍ Ma, J.K.; Caudell, J.J.; Jennelle, R.; Mourad, W.F.; Hamilton, R.; Pitman, K.; O 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II analysis of paclitaxel and cape

Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region

✍ Jens D Bentzen; Hanne Sand Hansen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## Background. The aim of this phase II study was to evaluate the antitumor activity and toxicity of a non‐platin–containing regimen with paclitaxel and capecitabine. ## Methods. Fifty patients with recurrent or disseminated squamous cell carcinoma were included in the study. The tre

Phase II study of induction and adjuvant

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck : A long term analysis for the Illinois Cancer Center

✍ Ilias Athanasiadis; Samuel Taylor IV; Everett E. Vokes; Harold J. Pelzer; Alfred 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

the following treatment was administered: Induction chemotherapy (cisplatin and infusional 5-

A Phase II Trial of Bryostatin-1 in Pati

A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

✍ David G. Pfister; John McCaffrey; Andrew J. Zahalsky; Gary K. Schwartz; Eric Lis 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 77 KB

Early Analysis of a Phase 2 Prospective

Early Analysis of a Phase 2 Prospective Trial Evaluating Accuracy of Triphasic PET/CT After RT for Head and Neck Squamous Cell Carcinoma

✍ Anderson, C.M.; Marquardt, M.; Graham, M.; Button, A.; Smith, B.; Menda, Y.; Weh 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase II trial of cisplatin and vinore

A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Enrique Espinosa; Pilar Zamora; Alfredo Millá; Serafin Morales; Raquel Molina; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv